Sohn HY - Search Results

1

Intracoronary brachytherapy--clinical state and pathophysiological considerations.

Krötz F, Sohn HY, Klauss V, Schiele TM. Krötz F, et al. Among authors: sohn hy. Curr Pharm Des. 2005;11(4):421-33. doi: 10.2174/1381612053382025. Curr Pharm Des. 2005. PMID: 15725063 Review.

2

Sustained platelet activation following intracoronary beta irradiation.

Krötz F, Schiele TM, Zahler S, König A, Rieber J, Kantlehner R, Pöllinger B, Dühmke E, Theisen K, Sohn HY, Klauss V. Krötz F, et al. Among authors: sohn hy. Am J Cardiol. 2002 Dec 15;90(12):1381-4. doi: 10.1016/s0002-9149(02)02878-3. Am J Cardiol. 2002. PMID: 12480050 Clinical Trial. No abstract available.

3

Impact of barotrauma on acute and late angiographic and clinical outcomes following angioplasty and beta-irradiation of coronary in-stent restenotic lesions.

Schiele TM, König A, Rieber J, Krötz F, Sohn HY, Kantlehner R, Pöllinger B, Dühmke E, Theisen K, Siebert U, Klauss V. Schiele TM, et al. Among authors: sohn hy. J Invasive Cardiol. 2004 Jan;16(1):14-9. J Invasive Cardiol. 2004. PMID: 14699217

4

Evolution of angiographic restenosis rate and late lumen loss after intracoronary beta radiation for in-stent restenotic lesions.

Schiele TM, Pöllinger B, Kantlehner R, Rieber J, König A, Seelig V, Krötz F, Sohn HY, Siebert U, Dühmke E, Theisen K, Klauss V. Schiele TM, et al. Among authors: sohn hy. Am J Cardiol. 2004 Apr 1;93(7):836-42. doi: 10.1016/j.amjcard.2003.12.020. Am J Cardiol. 2004. PMID: 15050485

5

Selective COX-2 inhibitors and risk of myocardial infarction.

Krotz F, Schiele TM, Klauss V, Sohn HY. Krotz F, et al. Among authors: sohn hy. J Vasc Res. 2005 Jul-Aug;42(4):312-24. doi: 10.1159/000086459. Epub 2005 Jun 20. J Vasc Res. 2005. PMID: 15976506 Free article. Review.

6

Three-year clinical follow-up after strontium-90/yttrium-90 beta-irradiation for the treatment of in-stent coronary restenosis.

Baierl V, Baumgartner S, Pöllinger B, Leibig M, Rieber J, König A, Krötz F, Sohn HY, Siebert U, Haimerl W, Dühmke E, Theisen K, Klauss V, Schiele TM. Baierl V, et al. Among authors: sohn hy. Am J Cardiol. 2005 Nov 15;96(10):1399-403. doi: 10.1016/j.amjcard.2005.06.087. Epub 2005 Sep 30. Am J Cardiol. 2005. PMID: 16275186

7

Cyclooxygenase inhibition and atherothrombosis.

Sohn HY, Krötz F. Sohn HY, et al. Curr Drug Targets. 2006 Oct;7(10):1275-84. doi: 10.2174/138945006778559102. Curr Drug Targets. 2006. PMID: 17073588 Review.

8

Prothrombotic potential of NSAID in ischemic heart disease.

Krötz F, Hellwig N, Schiele TM, Klauss V, Sohn HY. Krötz F, et al. Among authors: sohn hy. Mini Rev Med Chem. 2006 Dec;6(12):1351-5. doi: 10.2174/138955706778993030. Mini Rev Med Chem. 2006. PMID: 17168811 Review.

9

Antiplatelet drugs in cardiological practice: established strategies and new developments.

Krötz F, Sohn HY, Klauss V. Krötz F, et al. Among authors: sohn hy. Vasc Health Risk Manag. 2008;4(3):637-45. doi: 10.2147/vhrm.s2691. Vasc Health Risk Manag. 2008. PMID: 18827913 Free PMC article. Review.

10

Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial.

Wiemer M, König A, Rieber J, Sohn HY, Leibig M, Theisen K, Klauss V, Langer C, Lindner O, Horstkotte D, Schiele TM. Wiemer M, et al. Among authors: sohn hy. EuroIntervention. 2011 Jan;6(6):687-94. doi: 10.4244/EIJV6I6A117. EuroIntervention. 2011. PMID: 21205590 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters